Simulations Plus Aktie

15,70 EUR +0,10 EUR +0,64 %

08:08:36

FSE

18,23 USD -0,01 USD -0,03 %

21:31:05

BTT

Simulations Plus jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.323,94 Mio. EUR

Div. Rendite0,00%

WKN924294

ISINUS8292141053

SymbolSLP

Simulations Plus Aktien News

Sortieren:Datum Meistgelesen

19.11.24BusinesswireSimulations Plus to Participate in the BTIG Digital Health Forum

13.11.24BusinesswireSimulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

06.11.24BusinesswireSimulations Plus to Participate in the Stephens Annual Investment Conference

30.10.24BusinesswireSimulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

09.10.24BusinesswireSimulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

08.10.24BusinesswireSimulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

28.08.24BusinesswireSimulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

23.08.24BusinesswireSimulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

01.08.24BusinesswireSimulations Plus Releases DILIsym® X

30.07.24BusinesswireSimulations Plus Releases ADMET Predictor® Version 12

25.07.24BusinesswireSimulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum

11.07.24BusinesswireSimulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

20.06.24BusinesswireSimulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

18.06.24BusinesswireSimulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

12.06.24BusinesswireSimulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum

22.05.24BusinesswireSimulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

15.05.24BusinesswireSimulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software

04.04.24BusinesswireU.S. FDA Renews DILIsym® Software Licenses for 7th Year

20.03.24BusinesswireSimulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date

13.03.24BusinesswireSimulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

05.03.24BusinesswireSimulations Plus and the University of Bath Awarded New FDA Grant

15.02.24BusinesswireSimulations Plus Extends Collaboration with Major Toxicology Research Agency

13.02.24BusinesswireSimulations Plus Launches Corporate Development Initiative

06.02.24BusinesswireSimulations Plus to Participate in Upcoming Healthcare Conferences

30.01.24BusinesswireSimulations Plus Releases GastroPlus® Version 9.9

09.01.24BusinesswireSimulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant

03.01.24BusinesswireSimulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

20.12.23BusinesswireSimulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date

14.11.23BusinesswireSimulations Plus Outlines Paths to Win at 2023 Investor Day

08.11.23BusinesswireISoP New Board of Trustees Members Announced

31.10.23BusinesswireSimulations Plus to Host Investor Day on Tuesday, November 14th

11.10.23BusinesswireSimulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

21.09.23BusinesswireSimulations Plus Receives New FDA Grant Award

07.09.23BusinesswireSimulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors

24.08.23BusinesswireSimulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

15.08.23BusinesswireResearchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment

Simulations Plus News

Simulations Plus News: auf dieser Seite finden Sie alle Simulations Plus News und Nachrichten zur Simulations Plus Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Simulations Plus News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Simulations Plus News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.